Torrent Pharmaceuticals Limited
TORNTPHARM
Hisse Senetlerindeki Sıralama
#1203
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Hisse Fiyatı
$50.34
Piyasa Değeri
$19.15B
Değişim (1 gün)
-0.07%
Değişim (1 yıl)
23.64%
Ülke
IN
Ticaret Torrent Pharmaceuticals Limited (TORNTPHARM)
Kategori
Healthcare
Torrent Pharmaceuticals Limited (TORNTPHARM) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 23.45%
Torrent Pharmaceuticals Limited şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 23.45%'dir. 2024 yılı sonunda şirketin faaliyet marjı 51.25% idi.
Torrent Pharmaceuticals Limited için 2005 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
| Yıl | Faaliyet Marjı | Değiştir |
|---|---|---|
| 2026 (TTM) | 23.45% | -54.14% |
| 2025 | 51.13% | -0.23% |
| 2024 | 51.25% | 5.71% |
| 2023 | 48.48% | 3.08% |
| 2022 | 47.03% | -3.77% |
| 2021 | 48.87% | 1.14% |
| 2020 | 48.32% | 5.59% |
| 2019 | 45.76% | 1.55% |
| 2018 | 45.06% | -0.73% |
| 2017 | 45.39% | -24.75% |
| 2016 | 60.32% | 30.65% |
| 2015 | 46.17% | 0.00% |
| 2014 | 46.17% | 127.21% |
| 2013 | 20.32% | 17.73% |
| 2012 | 17.26% | 3.23% |
| 2011 | 16.72% | -11.91% |
| 2010 | 18.98% | 40.70% |
| 2009 | 13.49% | 8.35% |
| 2008 | 12.45% | 29.15% |
| 2007 | 9.64% | 12.22% |
| 2006 | 8.59% | -15.62% |
| 2005 | 10.18% | 0.00% |
Benzer şirketler veya rakipler için Faaliyet Marjı
| Şirket | Faaliyet Marjı | Faaliyet Marjı Farkı | Ülke |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -99.02% |
IN
|
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.